Cite
McPartland JC, Bernier RA, Jeste SS, et al. The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification. Front Integr Neurosci. 2020;14:16doi: 10.3389/fnint.2020.00016.
McPartland, J. C., Bernier, R. A., Jeste, S. S., Dawson, G., Nelson, C. A., Chawarska, K., Earl, R., Faja, S., Johnson, S. P., Sikich, L., Brandt, C. A., Dziura, J. D., Rozenblit, L., Hellemann, G., Levin, A. R., Murias, M., Naples, A. J., Platt, M. L., Sabatos-DeVito, M., Shic, F., Senturk, D., Sugar, C. A., Webb, S. J. (2020). The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification. Frontiers in integrative neuroscience, 1416. https://doi.org/10.3389/fnint.2020.00016
McPartland, James C, et al. "The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification." Frontiers in integrative neuroscience vol. 14 (2020): 16. doi: https://doi.org/10.3389/fnint.2020.00016
McPartland JC, Bernier RA, Jeste SS, Dawson G, Nelson CA, Chawarska K, Earl R, Faja S, Johnson SP, Sikich L, Brandt CA, Dziura JD, Rozenblit L, Hellemann G, Levin AR, Murias M, Naples AJ, Platt ML, Sabatos-DeVito M, Shic F, Senturk D, Sugar CA, Webb SJ. The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification. Front Integr Neurosci. 2020 Apr 09;14:16. doi: 10.3389/fnint.2020.00016. eCollection 2020. PMID: 32346363; PMCID: PMC7173348.
Copy
Download .nbib